Avise Analytics is the fastest growing equity research firm that authors institutional quality equity research reports, with special focus on Nano-Cap and Micro-Cap companies that are undervalued and lacks adequate coverage.
We offer full spectrum of equity research services ranging from initiating coverage and maintenance to market insights and technical analysis.
We offer investment research services across the entire life cycle from deal origination & evaluation, monitoring to strategy support.
We assist to evaluate investment ideas by providing in-depth qualitative & quantitative research and ongoing support services.
We prepare high-quality business plan, financial projection model, fund raising support, corporate presentation, and other PR services.
Our team of highly experienced analysts provides a wide range of tailored services in the field of equity, investment and financial research and investor relations to our diversified client base around the world.
Our free mobile app gives you real-time notifications on publication of short company stories for compelling investment ideas so that you never miss an opportunity!
As a step to effectively handle your research team’s workload as a business partner, our free mobile (and tablet friendly) application, also offer you a complete accessibility in tracking your project progress and billing and payment status at the tip of your finger any time.
Download the app for free now to explore our talent pool and feel the difference in outsourcing your work to us.
We pride ourselves in constantly delivering high-quality and scalable equity, investment and credit research solutions to our diversified client base across 9 countries. A snapshot of our key experience in past 3 years includes:
CLIENT
COVERAGE
FINANCIAL MODELS
PRSENTATIONS
Globalstar, Inc. (NYSE: GSAT), a premier mobile satellite services company, announced that its subsidiary Globalstar, In...
16 April, 2021No commentCytoKinetics, Inc. (NASDAQ: CYTK), a late-stage biopharmaceutical company, is developing therapeutics for the treatment ...
15 April, 2021No commentRigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is focused on developing innovative small molecule drugs that target hematolo...
14 April, 2021No commentBiotech Companies continue to show resurgence even in these challenging times, with more and more companies persevering ...
13 April, 2021No commentInnodata, Inc. (NASDAQ: INOD) is a leading global data engineering company that is using a combination of artificial int...
12 April, 2021No commentOntrak Inc (NASDAQ: OTRK), a virtual provider of AI-powered Telehealth solutions announced the signing of an updated con...
09 April, 2021No commentRed Cat Holdings Inc (OTCQB: RCAT), a premier brand in the Drone industry, reported record quarterly revenues for its fi...
08 April, 2021No commentSuper League Gaming, Inc (NASDAQ: SLGG) offers a video gaming and esports entertainment platform for amateur everyday pl...
06 April, 2021No commentMannKind Corporation (NASDAQ: MNKD) is a biopharmaceutical company that is leveraging its unique Technosphere Technology...
05 April, 2021No commentOuster Inc (NYSE: OUST) develops and delivers high-performance digital LiDAR solutions that empower robots, automotive, ...
01 April, 2021No commentBiotech Companies continue to show resurgence even in these challenging times, with more and more companies persevering ...
31 March, 2021No commentKnow Labs, Inc. (OTCQB: KNWN) formerly known as Visualant, is a premier non-invasive medical diagnostics company that is...
30 March, 2021No commentMadrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company, is developing novel therapeut...
26 March, 2021No commentAeva Technologies, Inc. (NYSE: AEVA) a developer of cutting-edge optical-based sensors for autonomous vehicles, debuted ...
25 March, 2021No commentReplimune group, Inc. (NASDAQ: REPL) is leveraging the power of its proprietary Immulytic platform to create a leading-e...
24 March, 2021No commentAvise Analytics is a professionally managed organization and understood job scopes & requirements very well. The report and analysis generated meet my expectations and will not hesitate to recommend others.
Deb C, Executive - Strategic Advisory Firm in Singapore
Delivered a high-quality set of documents that exceeded my expectations. Keep up the good work!!
Scott G, CEO - Investment Consultancy Firm in US
Great team. We ramped up our coverage universe quickly due to their help. I highly recommend them!
Robert W, MD - Independent Research Service Provider in US
High quality equity research provider that we now use for regular work
Craig S, Managing Director - Leading Independent Equities Provider in Australia
Excellent communication skills and a high commitment to client satisfaction.
Norman P, President - Emerging Portfolio Advisory Services Provider in US
Instrumental in helping us complete the research in such a tight timeline!
Bonnie C, Group GM, - Reputed Information Services Company in Hong-Kong
I have found Avise Analytics to be a great, cost-effective solution to providing both simple and complex finance-related articles for various blogs and newsletters. They are detailed oriented, consciences, respond well to direction, prompt and really know the finance industry.
Bill W, Director - U.S. Credit Card Financing Company